Unresectable because of inadequate hepatic reserve or tumor location
Inoperable because of performance status or comorbidity, local disease, or local disease with minimal extrahepatic disease only
HCC with metastatic disease or extensive liver tumor burden
National Comprehensive Cancer Network (NCCN®) makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
The survival benefits of STIVARGA demonstrated in RESORCE were in patients selected for good performance status and preserved liver function3,5
Monitor patients early and often throughout the course of treatment4